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A B S T R A C T 
Objective: To compare the live birth rate, multiple 
pregnancy rate, and obstetric outcomes of elective 
single and double embryo transfers.
Design: Case series with internal comparisons.
Setting: University affiliated hospital, Hong Kong.
Participants: Between October 2009 and December 
2011, 206 women underwent their first in-vitro 
fertilisation cycle. Elective single embryo transfer 
was offered to women who were aged 35 years or 
below, and had endometrial thickness of 8 mm or 
more and at least two embryos of good quality.
Main outcome measures: Live birth rate, multiple 
birth rate, and obstetric outcomes.
Results: Among the 206 eligible women, 74 
underwent an elective single embryo transfer and 
132 a double embryo transfer. The live birth rate was 
comparable in the two groups, being 39.2% in the 
elective single embryo transfer group and 43.2% in 
the double embryo transfer group, while the multiple 
pregnancy rate was significantly lower in the elective 
single embryo transfer group than the double embryo 
transfer group (6.9% vs 40.4%; P<0.001). Gestational 
ages and birth weights were comparable in the two 
groups. There was no significant difference between 
Live birth rate, multiple pregnancy rate, and 
obstetric outcomes of elective single and double 
embryo transfers: Hong Kong experience
Introduction
In-vitro fertilisation (IVF) treatment is an effective 
treatment for various causes of infertility and involves 
development of multiple follicles after ovarian 
stimulation, oocyte retrieval, and embryo transfer 
after fertilisation. Historically, multiple embryos were 
transferred to compensate for low rates of implantation 
for individual embryos as well as to achieve higher 
pregnancy rates. Consequently, IVF carried a high 
risk of multiple pregnancy and its associated adverse 
effects on mothers and children.1 In 2003 the Chairman 
New knowledge added by this study
• Elective single embryo transfer decreased the multiple pregnancy rate without compromising the live birth rate 
in women with a good prognosis undergoing in-vitro fertilisation.
Implications for clinical practice or policy
• Elective single embryo transfer should be offered to women with a good prognosis and the care provider should 
promote this policy through education.
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of the European Society of Human Reproduction 
and Embryology (ESHRE) commented that assisted 
reproduction techniques should result in the birth of 
one healthy child and that a twin pregnancy should be 
regarded as a complication.2
 In January 2013, the “Code of Practice on 
Reproductive Technology & Embryo Research” 
issued by the Council on Human Reproductive 
Technology of Hong Kong stipulated that no more 
than three embryos should be placed in a woman 
in any one cycle.3 In August 2001, the Human 
ORIGINAL ARTICLE
the two groups with respect to the rate of preterm 
delivery and antenatal complications (27.6% vs 
43.9%, respectively; P>0.05).
Conclusion: In this selected population, an elective 
single embryo transfer policy decreases the multiple 
pregnancy rate without compromising the live birth 
rate. The non-significant difference in antenatal 
complications may be related to the small sample 
size.
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選擇性單胚胎移植和雙胚胎移植的活產率、 
多胎率和懷孕結果：香港經驗
柴逸蘭、楊穎兒、李芷茵、李幸奐、劉綺蘭、楊樹標、	
何柏松、吳鴻裕
目的：比較選擇性單胚胎移植和雙胚胎移植的活產率、多胎率和懷孕
結果。
設計：具內部對比的病例系列研究。
安排：香港一所大學附屬醫院。
參與者：2009年10月至2011年12月期間，206位婦女首次接受體外受
精。為35歲或以下，並子宮內膜厚度有8毫米或以上以及至少有兩個
質量好的胚胎的婦女提供選擇性單胚胎移植。
主要結果測量：活產率、多胎率和懷孕結果。
結果：206名符合條件的婦女中，74例進行選擇性單胚胎移植，另
132例進行雙胚胎移植。兩組的活產率相若，單胚胎移植組為39.2%，
雙胚胎移植組為43.2%；而單胚胎移植組的多胎率比雙胚胎移植組明
顯較低（6.9%比40.4%；P<0.001）。兩組的胎齡和出生體重相若。
兩組之間在早產率及產前併發症方面無顯著差異（27.6%比43.9%；
P>0.05）。
結論：在本研究的參與者中，選擇性單胚胎移植可降低多胎妊娠率而
不影響活產率。產前併發症的非顯著差異可能與研究人數少相關。
Fertilisation and Embryology Authority in the UK 
recommended reducing the number of embryos that 
should be transferred in a single IVF treatment cycle 
from three to two.4
 In 2001, ESHRE recommended elective single 
embryo transfer (eSET) for women aged under 
34 years at the time of their first attempt, as soon 
as they had obtained a top-quality embryo.5 In 
2008, the British Fertility Society, in conjunction 
with the Association of Clinical Embryologists, 
introduced guidelines for eSET in the UK that aimed 
to reduce IVF multiple pregnancy rates to less than 
10%.6 Meta-analyses have shown that in a selected 
population, compared with double embryo transfer 
(DET), eSET could reduce multiple pregnancy rates 
significantly, without compromising cumulative 
pregnancy rates.7,8
 Our centre offered eSET to eligible women in 
order to reduce the multiple pregnancy rate. The 
aim of this study was to compare the live birth rate, 
multiple pregnancy rate, and obstetric outcomes 
after eSET and DET in mothers having their first IVF/
intra-cytoplasmic sperm injection (ICSI) attempt.
Methods
This was a retrospective study carried out at the 
Centre of Assisted Reproduction and Embryology, 
Queen Mary Hospital, The University of Hong Kong, 
Hong Kong. Clinical details of all treatment cycles 
were prospectively entered into a computerised 
database, and checked for correctness and 
completeness on a regular basis. For this study, data 
were retrieved for analysis and ethics committee 
approval was deemed not necessary for retrospective 
analysis of data. 
Patients
In our programme, a maximum of two embryos were 
replaced, irrespective of the woman’s age. Women 
were eligible for eSET if they were ≤35 years of age 
at the time of the embryo transfer, were undergoing 
their first IVF cycle, had an endometrial thickness of 
≥8 mm, and had at least two good-quality embryos 
available for transfer or freezing. Good-quality 
embryos were defined by their morphological 
features and cleavage rate, and included embryos 
with less than 25% fragmentation and four cells at 
day 2. Eligible patients were individually counselled 
about eSET. Women who opted for eSET would have 
one embryo replaced (eSET group), while those who 
opted for DET had two embryos transferred (DET 
group).
Ovarian stimulation and in-vitro 
fertilisation/intra-cytoplasmic sperm 
injection procedures
All women were treated either with the long 
gonadotropin-releasing hormone (GnRH) agonist 
protocol or the GnRH antagonist protocol for 
pituitary down-regulation. The details of the long 
protocol for the ovarian stimulation regimen, 
handling of gametes, as well as standard insemination 
and ICSI were as previously described.9 In short, 
women received buserelin (Suprecur; Hoechst, 
Frankfurt, Germany) nasal spray 150 μg 4 times a 
day starting from the mid-luteal phase of the cycle 
preceding the treatment cycle, followed by human 
menopausal gonadotropins (hMG) or recombinant 
follicle-stimulating hormone (FSH) for ovarian 
stimulation after return of a period. In the GnRH 
antagonist protocol, after confirming a basal serum 
oestradiol level, ovarian stimulation was started 
with either hMG or recombinant FSH. Ganirelix 
(NV Organon; Swords Co, Dublin, Ireland) 250 μg 
was started from the sixth day of stimulation. The 
starting dose of gonadotropin was based on the 
baseline antral follicle count. 
 Transvaginal ultrasonography was used to 
monitor the ovarian response. When the mean 
diameter of the leading follicle reached 18 mm and 
there were at least three follicles reaching a mean 
diameter of 16 mm or more, human chorionic 
gonadotropin (hCG; Pregnyl; Organon, Oss, The 
Netherlands) 5000 or 10  000 units or Ovidrel 
(Merck Serono, Modugno, Italy) 250 μg was given 
and oocytes were collected about 36 hours later. 
Fertilisation was carried out in vitro either by 
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conventional insemination or ICSI depending on 
semen parameters. Women were allowed to have 
replacement of at most two embryos 2 days after 
oocyte retrieval. A progesterone pessary (Endometrin 
100 mg twice per day; Ferring Pharmaceuticals, 
Parsippany [NJ], US) was administered from the 
day of embryo transfer for 2 weeks to enable luteal 
support. Pregnancies were confirmed by positive 
urine hCG tests and transvaginal ultrasonographic 
evidence of a gestational sac.
Collection of clinical information
Clinical information including age, body mass index, 
basal serum levels of FSH, and baseline antral follicle 
counts were collected. During IVF treatment, such 
data included days of stimulation, total dosage 
of gonadotropin, oestradiol level on day of hCG, 
number of oocytes retrieved, number of available 
embryos, number of good-quality embryos, as well 
as pregnancy and miscarriage rates. 
 Clinically, pregnancy was defined as the 
presence of a gestational sac by ultrasonography, 
whereas the miscarriage rate per clinical pregnancy 
was defined as the proportion of patients whose 
pregnancy failed to develop before 20 weeks of 
gestation. Pregnancy outcome was collected from 
all pregnant women by a postal questionnaire or by 
phone. Live birth was defined as the delivery of a 
fetus with signs of life after 24 completed weeks of 
gestational age, and the multiple pregnancy rate was 
calculated as the number of multiple pregnancies 
divided by the number of clinical pregnancies, 
expressed as a percentage. Obstetric outcomes 
including antenatal complications, gestational age 
at delivery, mode of delivery, and birth weight were 
also recorded. 
Statistical analysis
The primary outcome measure was the live birth 
rate and secondary outcomes included the multiple 
pregnancy rate and obstetric outcomes. Statistical 
analysis for the comparison of mean values was 
performed using Mann-Whitney and Student’s t 
tests, as appropriate. The Chi squared and Fisher’s 
exact tests were used to compare categorical 
variables. Statistical analysis was carried out using 
the Statistical Package for the Social Sciences 
(Windows version 20.0; SPSS Inc, Chicago [IL], 
US). A two-tailed P value of <0.05 was considered 
statistically significant.
Results
In all, 206 women undergoing their first IVF cycle 
from October 2009 to December 2011 met the 
inclusion criteria. A total of 74 women chose eSET 
and 132 chose DET. Patient and cycle characteristics 
are shown in Tables 1 and 2, respectively. Women 
who opted for eSET were significantly younger than 
those opting for DET, and had a significantly higher 
proportion of good-quality embryos than those in 
the DET group. 
 The IVF and obstetric outcomes are shown in 
Table 3. Among women with eSET, 40 (54.1%) had 
a positive pregnancy test; two were biochemical 
pregnancies, eight miscarried, and one was an ectopic 
pregnancy. There was one pair of monozygotic and 
one pair of dizygotic twins in the eSET group. In 
women having DET, the positive pregnancy test rate 
was 58.3% (n=77/132); there were nine biochemical 
pregnancies, seven miscarriages, and four ectopic 
pregnancies. In the DET group, the multiple 
pregnancy rate was 40.4%, which was significantly 
higher than that in the eSET group (P<0.001). There 
were two sets of triplets, of which one underwent 
fetal reduction to a singleton and the other had fetal 
reduction to twins. One woman in the eSET group 
TABLE 1.  Demographic and clinical characteristics of the patients referred for sperm 
cryopreservation (n=130)*
eSET (n=74) DET (n=132) P value
Age of women (years) 31.8 ± 2.0 32.7 ± 2.3 <0.05
Body mass index (kg/m2) 21.2 ± 2.6 21.9 ± 2.6 0.221
Primary subfertility (%) 72.9 71.0 0.822
Duration of infertility (years) 4.2 ± 2.6 3.9 ± 2.2 0.754
Indication for IVF 0.212
Endometriosis 7 (9.5) 6 (4.5)
Tuboperitoneal factor 18 (24.3) 25 (18.9)
Male factor 36 (48.6) 61 (46.2)
Unexplained 9 (12.2) 20 (15.2)
Mixed factors 4 (5.4) 20 (15.2)
Basal FSH (IU/L) 7.6 ± 1.8 8.0 ± 3.1 0.971
Baseline antral follicle count 14.7 ± 8.1 13.9 ± 8.3 0.449
Percentage of ICSI (%) 35.1 34.1 0.880
Abbreviations: DET = double embryo transfer ; eSET = elective single embryo transfer ; 
FSH = follicle-stimulating hormone; ICSI = intra-cytoplasmic sperm injection; IVF = in-
vitro fertilisation
* Data are shown as mean ± standard deviation, %, or No. (%)
TABLE 2.  Cycle characteristics*
eSET (n=74) DET (n=132) P value
Duration of stimulation (days) 10.9 ± 2.5 10.9 ± 2.0 0.657
Dosage of gonadotropins (IU) 2048 ± 920 2139 ± 779 0.065
Oestradiol level (pmol/L) 11 986 ± 4966 9545 ± 4232 0.065
No. of oocytes retrieved 10.9 ± 4.3 10.6 ± 5.7 0.245
No. of embryos at day 2 6.7 ± 3.0 6.1 ± 3.8 0.060
No. of good-quality embryos 4.1 ± 2.0 3.3 ± 1.7 0.002
Abbreviations: DET = double embryo transfer ; eSET = elective single embryo transfer
* Data are shown as mean ± standard deviation
#  Elective single and double embryo transfers  # 
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and four in the DET group were lost to follow-up for 
their obstetric outcomes. Overall, the live birth rate 
was comparable in the eSET and DET groups (39.2% 
vs 43.2%, respectively).
 The mean gestational age at birth and 
the median birth weight were not significantly 
different in the eSET group compared with the 
DET group (38.6 ± 2.2 vs 37.9 ± 2.3 weeks and 
2950 [interquartile range, 2830-3157] g vs 2785 
[2475-3200] g, respectively). The preterm delivery 
rate (defined as delivery at <37 weeks) and the 
frequencies of antenatal complications (including 
gestational diabetes, gestational hypertension, pre-
eclampsia, and placenta praevia) were higher in the 
DET group, although the difference did not reach 
statistical significance. 
Discussion
The risk of multiple pregnancy has been a concern 
in IVF/ICSI as it is associated with adverse maternal 
and neonatal outcomes.1 This is the first study 
reporting live birth rates and obstetric outcomes 
after eSET and DET in a selected population in 
Hong Kong. Our study confirms recent literature 
findings,7,8 by showing that eSET can significantly 
reduce the multiple pregnancy rate without adversely 
affecting the live birth rate in young women with 
good ovarian function. No triplets were observed 
in the eSET group, but rather unexpectedly it did 
contain two pairs of twins; one was monozygotic and 
one dizygotic. Dizygotic twin pregnancy following 
a single embryo transfer was a rare event, and 
suggestive of a spontaneous pregnancy occurring 
concurrently with one due to IVF.10 The multiple 
pregnancy rate of 40.4% in the DET group and the 
live birth rates in our study (39.2% and 43.2% in the 
eSET and DET groups, respectively) were similar to 
or higher than those previously reported.7,11-14
 Our study showed that the obstetric outcomes 
were not significantly different in the two groups. 
Antenatal complications were more common in the 
DET group (43.9% vs 27.6% in eSET group), although 
the difference did not reach statistical significance 
(P=0.142). Regrettably, data on the Apgar score, 
neonatal intensive care unit admissions, and 
perinatal mortality were not available. A recent meta-
analysis by Grady et al15 showed that eSET babies 
were associated with decreased risks of preterm 
birth and low birth weight than those involving DET. 
Moreover, eSET singletons had a higher birth weight 
and lower preterm birth rate than DET singletons, 
which was postulated to be related to the vanishing 
twin.16 Our study failed to demonstrate the difference 
but this could be attributed to the small sample size. 
 Our study was limited by its retrospective 
nature and small sample size. Also, women having 
eSET were significantly younger than those having 
DET, which might lead to possible confounding. 
The younger mean age in the eSET group could 
explain the higher number of good-quality embryos 
available for transfer, which might have an impact 
on the cumulative pregnancy rate. The cumulative 
pregnancy rate was not always included as many 
women still had frozen embryos, but this would be an 
important aspect to look into in the future. Another 
bias was that women were allowed to choose between 
one or two embryos to transfer, instead of allocation 
by randomisation. Nonetheless, it reflected the 
actual situation in our centre. Blastocyst transfer is 
not routinely performed in out unit, because of the 
possible increased risk of congenital abnormalities 
and preterm labour,17,18 although the pregnancy and 
live birth rates of the fresh cycle may be higher than 
those following early cleavage stage transfer.19
 The eSET policy is increasingly being applied 
and in a country like Belgium, the law requires eSET 
for all patients aged under 36 years during their 
first two IVF attempts.20 In Hong Kong, eSET is not 
imposed and suitable women were given the choice 
of eSET and DET with detailed counselling. From our 
data, only a third of the women chose eSET, which 
suggests that such women are still resistant to eSET. 
Child et al21 found that 41% of women having assisted 
reproductive technology were actually inclined to 
prefer a twin pregnancy, and some women waiting 
for IVF treatment viewed severe child disability 
outcomes more desirable than having no child at 
all.22 This barrier might be overcome by providing 
TABLE 3.  In-vitro fertilisation and obstetric outcomes*
eSET (n=74) DET (n=132) P value
Positive pregnancy test rate 40 (54.1) 77 (58.3) 0.552
Clinical pregnancy rate 38 (51.4) 68 (51.5) 0.240
Miscarriage <20 weeks 8/38 (21.1) 7/68 (10.3) 0.128
Ectopic pregnancy 1/40 (2.5) 4/77 (5.2) 0.494
Stillbirth 0 0 1.000
Live birth rate 29 (39.2) 57 (43.2) 0.657
Multiple birth rate 2/29 (6.9) 23/57 (40.4) <0.001
Preterm delivery <37 weeks 3/29 (10.3) 8/57 (14.0) 0.628
Preterm delivery <32 weeks 1/29 (3.4) 3/57 (5.3) 0.706
Gestation (weeks) 0.102
Mean ± standard deviation 38.6 ± 2.2 37.9 ± 2.3
Median (range) 38.7 (30.1-41.0) 38.2 (27.6-41.1)
Birth weight (g) 0.202
Mean ± standard deviation 2913 ± 480 2787 ± 639
Median (interquartile range) 2950 (2830-3157) 2785 (2475-3200)
Antenatal complications 8/29 (27.6) 25/57 (43.9) 0.142
Abbreviations: DET = double embryo transfer ; eSET = elective single embryo transfer
* Data are shown as No. (%) or mean ± standard deviation, unless otherwise stated
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educational material to women so as to improve 
their knowledge on outcomes and risks of multiple 
pregnancies.23 The feasibility of eSET also relies on 
improving outcomes with cryopreserved embryos 
and the technique on vitrification. Information from 
the present study may also improve the uptake of 
eSET in the unit.
 Our study confirms that when compared 
with DET, eSET can reduce the rate of multiple 
pregnancies without compromising the live birth 
rate in the fresh cycle. Elective SET should be offered 
to patients with a good prognosis and IVF centres 
should promote it, whenever appropriate, through 
provider and patient education.
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